
Company
Meeting Niche Market Needs
CMP Pharma is a specialty pharmaceutical company that addresses critical needs for niche markets within the pharmaceutical and life science industries by developing and manufacturing a portfolio of high value semi-solid and liquid products.
Our products include leading, high-quality branded and generic prescription, non-prescription and skin care pharmaceutical products, which we distribute to hospital, long-term care, and retail channels.
Our Products
Improving Patients’ Quality of Life
CMP Pharma continually develops and manufactures our high-value portfolio of branded and generic prescription (Rx) and non-prescription semi-solid and liquid products. We serve hospital, long-term care, and retail markets.
Our Leadership
Governance and Growth Through Innovation
The leadership at CMP Pharma focuses on providing support, encouragement, and inspiration to the workforce. We foster innovation and leadership at all levels, and firmly believe that a functional foundation of governance promotes corporate growth and stability.
Our management team’s diverse backgrounds support and enhance our company’s market presence.
Our Capabilities
Where Experience Meets Expertise
Based in Farmville, North Carolina, CMP Pharma delivers reliable and affordable solutions to niche pharmaceutical markets. CMP Pharma’s 35,000 square foot facility houses laboratories, production, packaging, and temperature-controlled storage capabilities.
This facility specializes manufacturing solutions, suspensions, powders, creams and ointments.
Latest News
CMP Pharma, Inc Announces That CaroSpir®, The First And Only FDA-Approved Spironolactone Oral Suspension, Is Now Available
CMP Pharma today announced that CaroSpir® (Spironolactone Oral Suspension, 25 mg/5 mL), the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone, is now available. CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution.